A family representative for Rodiyat Alabede, a 22-year-old international student who died after donating plasma at a Winnipeg plasma donation center, is urging Health Canada to reopen the investigation into her death. Katherine Lanteigne, an advocate for safe blood practices, revealed that Alabede suffered a cardiac arrest after her donation at Grifols on Taylor Avenue. The chief medical examiner’s report indicated that her cause of death was dilated cardiomegaly, an enlarged heart. Lanteigne emphasized that the circumstances of Alabede’s death should be reevaluated, noting that the stress from the donation could have exacerbated her underlying condition. Health Canada previously concluded its investigation into Alabede’s death and another fatality at a Grifols center, stating there was no link to the donation process, although it acknowledged that unknown pre-existing medical conditions could influence such outcomes.
Why It Matters
The case highlights ongoing concerns regarding the safety of paid plasma donation practices in Canada, particularly following two deaths associated with Grifols plasma centers in Winnipeg. Health Canada has stated that Canada maintains one of the safest blood systems globally, yet the deaths have raised questions about donor health monitoring and the potential risks associated with plasma donation, especially for individuals with pre-existing medical conditions. Grifols has been operating in Canada since acquiring Canadian Plasma Resources in 2022, and this situation underscores the need for regulatory vigilance and transparency in the for-profit plasma donation sector to ensure donor safety.
Want More Context? 🔎
